Shariq Anis Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Shariq Anis Khan has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Salman El Khalid
The Kidney Centre, Post Graduate Training Institute, Karachi-Pakistan
4 shared publications - Adnan Siddiq Awan
PAF Hospital, Karachi-Pakistan
3 shared publications - Imran Sharif
Department of Urology, Faculty of Surgery, The Kidney Centre PGTI, Karachi-Pakistan
3 shared publications - Jahanzeb Shaikh
The Kidney Centre, Post Graduate Training Institute, Karachi-Pakistan
2 shared publications - Muhammad Hammad Ali Mithani
Dow University of Health Sciences, Karachi, Pakistan
2 shared publications - Shoaib Mithani
Department of Pharmacology, Faculty of Pharmacy, Jinnah Sindh Medical University, Karachi-Pakistan
2 shared publications
Latest Publications
- Open Access
- 1 September 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (3) , 371-377
Guy’s Stone Score: A Predictive Tool for Outcomes of Percutaneous Nephrolithotomy
Background: Predicting stone clearance before intervention can be useful to plan the modality of treatment and calculate the cost of procedures. Therefore, this study aims to determine the frequency of successful stone clearance in a patient undergoing percutaneous nephrolithotomy (PCNL) with different categories of Guy's Stone Score (GSS). Methodology: A total of 115 patients undergoing standard PCNL from January to December 2018 were included in this study. According to GSS I-IV, patients were then categorized into four groups after having pre-operative Computed Tomography of Kidney, Ureter, and Bladder (KUB). All the patients received standard general anesthesia and underwent standard PCNL in a prone position. The Percutaneous nephrostomy 18-gauge needle is passed into the pelvis of the kidney, Pelvi-calyceal system opacified and confirmed using fluoroscopy, a guidewire is passed, and 30 Fr Amplatz sheath is introduced after serial dilatation. A 26 Fr nephroscope is then inserted through the working sheath, and the stone is fragmented and removed. Finally, a nephrostomy drain tube is kept at the puncture site. The outcome was accessed in terms of stone clearance rate after PCNL on the 2nd postoperative day using the radiological modality of CT-KUB. Results: Among the 115 patients here were 48(41.7%) categorized as GSS I, 26(22.6%) categorized as GSSII, 20(17.4%) categorized as GSS III, and 21(18.3%) categorized as GSS IV. The overall stone clearance observed was 64.3%, individual stone clearance was GSS I=91.66%, GSS II=53.84%, GSS III=50%, and GSS IV=28.57%. Stone clearance among the different GSS categories was significantly different (pConclusion: The Guy's Stone Score, based on CT scan findings, is a significant system in predicting successful stone-free rates. It is a convenient, quick, and efficient tool for pre-operative assessment, and it can be incorporated as a mandatory protocol before planning PCNL.
- 1 September 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (3) , 371-377
Open AccessGuy’s Stone Score: A Predictive Tool for Outcomes of Percutaneous Nephrolithotomy
Background: Predicting stone clearance before intervention can be useful to plan the modality of treatment and calculate the cost of procedures. Therefore, this study aims to determine the frequency of successful stone clearance in a patient undergoing percutaneous nephrolithotomy (PCNL) with different categories of Guy's Stone Score (GSS). Methodology: A total of 115 patients undergoing standard PCNL from January to December 2018 were included in this study. According to GSS I-IV, patients were then categorized into four groups after having pre-operative Computed Tomography of Kidney, Ureter, and Bladder (KUB). All the patients received standard general anesthesia and underwent standard PCNL in a prone position. The Percutaneous nephrostomy 18-gauge needle is passed into the pelvis of the kidney, Pelvi-calyceal system opacified and confirmed using fluoroscopy, a guidewire is passed, and 30 Fr Amplatz sheath is introduced after serial dilatation. A 26 Fr nephroscope is then inserted through the working sheath, and the stone is fragmented and removed. Finally, a nephrostomy drain tube is kept at the puncture site. The outcome was accessed in terms of stone clearance rate after PCNL on the 2nd postoperative day using the radiological modality of CT-KUB. Results: Among the 115 patients here were 48(41.7%) categorized as GSS I, 26(22.6%) categorized as GSSII, 20(17.4%) categorized as GSS III, and 21(18.3%) categorized as GSS IV. The overall stone clearance observed was 64.3%, individual stone clearance was GSS I=91.66%, GSS II=53.84%, GSS III=50%, and GSS IV=28.57%. Stone clearance among the different GSS categories was significantly different (pConclusion: The Guy's Stone Score, based on CT scan findings, is a significant system in predicting successful stone-free rates. It is a convenient, quick, and efficient tool for pre-operative assessment, and it can be incorporated as a mandatory protocol before planning PCNL.
- Open Access
- 14 April 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (2) , 156-160
Transurethral Resection of Prostate and Blood loss: Efficacy of Dutasteride in reducing perioperative blood loss.
Background: Benign Prostatic Hyperplasia (BPH) is the most common urological cause of urinary obstruction, affecting men above 50 years of age. Medical therapy used for managing BPH includes various medical regimes, including 5-alpha reductase inhibitors (5ARI), namely Dutasteride and more. The study aimed to evaluate the efficacy of four weeks' prior treatment with dutasteride on per-operative blood loss in patients of BPH undergoing transurethral resection of the prostate. Methodology: A prospective observational study was conducted from January to December 2019 at the Kidney Centre, Karachi, Pakistan. A total of 64 patients were included and divided into two groups. Group A patients were those who had been taking dutasteride (0.5 mg/day) for four weeks or more before surgery, and group B patients were not taking dutasteride drug before surgery. All patients underwent standard TURP, and the intra-operative blood loss was calculated. The collected data was analyzed using SPSS version 22.0. Results: In our study, there was a significantly less hemoglobin drop (1.2 gm vs. 2.2 gm) during prostate surgery in patients using dutasteride than those who were not using dutasteride. Conclusion: This study has revealed that the use of dutasteride four weeks before surgery significantly reduces intra-operative bleeding.
- 14 April 2021
- Published by Advance Educational Institute and Research Center (Publications) in International Journal of Endorsing Health Science Research (IJEHSR)
- Vol. 9 (2) , 156-160
Open AccessTransurethral Resection of Prostate and Blood loss: Efficacy of Dutasteride in reducing perioperative blood loss.
Background: Benign Prostatic Hyperplasia (BPH) is the most common urological cause of urinary obstruction, affecting men above 50 years of age. Medical therapy used for managing BPH includes various medical regimes, including 5-alpha reductase inhibitors (5ARI), namely Dutasteride and more. The study aimed to evaluate the efficacy of four weeks' prior treatment with dutasteride on per-operative blood loss in patients of BPH undergoing transurethral resection of the prostate. Methodology: A prospective observational study was conducted from January to December 2019 at the Kidney Centre, Karachi, Pakistan. A total of 64 patients were included and divided into two groups. Group A patients were those who had been taking dutasteride (0.5 mg/day) for four weeks or more before surgery, and group B patients were not taking dutasteride drug before surgery. All patients underwent standard TURP, and the intra-operative blood loss was calculated. The collected data was analyzed using SPSS version 22.0. Results: In our study, there was a significantly less hemoglobin drop (1.2 gm vs. 2.2 gm) during prostate surgery in patients using dutasteride than those who were not using dutasteride. Conclusion: This study has revealed that the use of dutasteride four weeks before surgery significantly reduces intra-operative bleeding.
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 157-164
Is Routine Measurement of Post-operative Hemoglobin and Electrolytes Necessary in Every Patient After Transurethral Resection of the Prostate?
- 1 December 2018
- Published by Galenos Yayinevi in Journal of Urological Surgery
- Vol. 5 (4) , 157-164
Is Routine Measurement of Post-operative Hemoglobin and Electrolytes Necessary in Every Patient After Transurethral Resection of the Prostate?